Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341080 · ClinicalTrials.gov registry record · Phase 2
Varenicline for Gait and Balance Impairment in Parkinson Disease
A Phase 2 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01341080 is a Phase 2 study that has completed, run by Rush University Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT01341080, a Phase 2 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if varenicline is effective in improving gait and balance impairment in patients with Parkinson disease.
Interventions
- DRUG Varenicline
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-12-28 |
| Est. Completion | 2018-11-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341080
The ClinicalTrials.gov registry entry for NCT01341080 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline is the first listed.
NCT01341080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341080 about?
NCT01341080 is a clinical study titled "Varenicline for Gait and Balance Impairment in Parkinson Disease". The purpose of this study is to determine if varenicline is effective in improving gait and balance impairment in patients with Parkinson disease.
What is the current status of trial NCT01341080?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2010-12-28. Estimated completion is 2018-11-02.
What interventions are being tested in trial NCT01341080?
The interventions under investigation include: Varenicline (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT01341080?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.